Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
30 May, 2026, 12.52 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
22 Apr, 2026, 10.08 PM IST
Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
08 Apr, 2026, 01.28 PM IST
Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
13 Sep, 2024, 11.08 AM IST
Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
10 May, 2024, 08.30 PM IST
Sanofi India board OKs demerger of consumer health businessDrug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. Th...
11 May, 2023, 12.45 AM IST
Hold Sanofi India, target price Rs 6270: ICICI DirectSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals s...
28 Feb, 2023, 10.30 AM IST
Buy Sanofi India, target price Rs 8500: Centrum BrokingSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14647.01 Crore) operating in Pharmaceutic...
28 Jul, 2022, 08.32 AM IST
Buy Sanofi India, target price Rs 9250: Sharekhan by BNP ParibasSanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT a...
02 May, 2022, 08.52 AM IST
Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
24 Feb, 2022, 10.11 AM IST
Sanofi's valuations are attractive: Why it is stock pick of weekSanofi India’s management has adopted cost control measures and has lowered promotional spends, which was visible in 2020. Its digital push...
04 May, 2021, 09.52 AM IST
Sanofi India shares hit 52-week high on Q4 resultsThe stock witnessed similar movement on the NSE as well, where it opened at 7,549.95.
26 Feb, 2020, 01.33 PM IST
Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
16 Sep, 2019, 01.40 PM IST
Sanofi India stock likely to be re-rated on company's improving fundamentalsHowever, unlike other multinational pharmaceutical companies, Sanofi India was not analysts’ favourite for quite some time.
27 Jan, 2014, 11.40 PM IST
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: Report
French drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
29 Jul, 2010, 02.18 PM IST
- Sun's EPS may take a knock if it stops cancer drug sale
The stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...
10 Apr, 2010, 01.05 AM IST
- Sanofi-Aventis revises open offer for Aventis Pharma
The schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...
21 Jun, 2006, 08.20 PM IST